Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US. - Shao, Hui; Alsaleh, Abdul Jabbar Omar; Dex, Terry; Lew, Elisheva; Fonseca, Vivian (Diabetes Therapy, 2022)